Application of the Sponge Model Implants in the Study of Vaccine Memory in Mice Previously Immunized with LBSap

1. Introduction

The sponge implant has been applied as an important in vivo model for the study of angiogenesis and inflammatory processes ​[1,2,3,4]​. After implantation in the subcutaneous compartment, the acellular and avascular sponge matrix induces the migration, proliferation, and accumulation of inflammatory cells, angiogenesis, and extracellular matrix deposition in its trabeculae ​[1,5]. The sponge implant model allows the sequential study of the inflammatory infiltrate through histomorphometric and biochemical analyses, using the activity of the enzymes and myeloperoxidase (MPO) and N-acetyl-glucosaminidase (NAG) to indirectly determine the activation of neutrophils and macrophages ​[4,6,7,8]​. Furthermore, since the tissue reaction to the sponge implant is circumscribed by a connective tissue capsule, it is also possible to assess the chemokine and cytokine profile in this microenvironment [4,5,9,10,11].

Notably, the sponge implant can be used to analyze the immune response in a controlled microenvironment, which represents a preliminary step in the development of an in vivo platform to test potential biomolecules. Many studies investigate this compartmentalized microenvironment in response to implant-associated anti-inflammatory or anti-angiogenic molecules ​[2,5,10,12,13,14,15,16,17,18,19,20,21,22,23]. The characterization of the immune events, including leukocyte immunophenotyping, cell activation, and the cytokine profile in sponge implanted in mice (Swiss, BALB/c and C57BL/6), demonstrated the influence of the genetic background with the inflammatory kinetics [11]. The appropriate time-points after the implant sponge as the platform of biomolecules screening was described according to the mice background: Day5 post-implant for Swiss mice, Day7 for BALB/c mice, and Day6 for C57BL/6 mice. Those time-points disclosed minor inflammation triggered by the sponge that induced an expected foreign body reaction post-implant [11]. Among the possible applications of studies using the sponge implant as a model, we highlight the possibility of trialing antigen candidates to compose protective vaccine formulations.

In this context, our group has described the ability of LBSap vaccine (composed by Leishmania braziliensis antigens associated with saponin adjuvant) to trigger a protective immune response in mice, hamsters, and dogs [24,25,26,27,28,29,30,31,32,33,34,35]. These studies supported the LBSap vaccine as a formulation presenting protective antigens useful for validating the sponge implant as model for memory immune response analyses. This new in vivo compartmentalized platform could be employed to optimize the screening of potential antigens required in protective vaccines. Thus, this study aimed to evaluate the sponge implant model in a vaccine memory test using the LBSap vaccine as a reference to improve the understanding of vaccine immunogenicity to establish a new model for in vivo tests. For this purpose, the immune response was further characterized using a prime (vaccine) and boost (antigen inoculation at sponge implant) protocol.

2. Materials and Methods

2.1. Animals

Male Swiss, BALB/c, and C57BL/6 mice (8–10 weeks old; n=20 mice) were provided by the Centro de Ciência Animal (CCA) at Universidade Federal de Ouro Preto (UFOP), Brazil. The animals were kept in ventilated racks with food and water ad libitum throughout the study, with intermittent light/dark cycles every 12 hours. The experimental design was approved by the Ethical Committee for Animal Studies (CEUA/UFOP, # 014/2011).

2.2. Sponge Implants

All the procedures were performed as described by [11]. Briefly, disk-shaped (5mmx8mm) polyether-polyurethane sponges were soaked overnight in 70% v/v ethanol and boiled in distilled water for 15 min before implantation. The mice were anesthetized by intraperitoneal injection of ketamine (150 mg kg−1) plus xylazine (10 mg kg−1) and the dorsal fur was shaved and the skin wiped with 70% v/v ethanol. The sponge disks were subcutaneously implanted throughout a 1-cm long dorsal mid-line incision and the animals were monitored daily for discomfort /distress or signs of opportunistic infection.

2.3. Experimental Design

The dynamics of phenotypic and functional changes in the sponge microenvironment were previously reported ​[11] to support the selection of the best post-implantation time, since this information is crucial for use in biomolecule screening assays. Therefore, Day 5/Swiss, Day 7/BALB/c, and Day 6/C57BL/6 were chosen for an immunological memory study ​[11]​. The sponge model was applied to the investigation of vaccine memory in previously immunized animals. The experimental design, study groups, and timeline are provided in Figure 1.

The animals were divided into three control groups (Figure 1): Saline/Saline (S/S): consisted of three saline inoculums, subcutaneously, with a 14-day interval and a new saline inoculum performed inside the sponge implant 14 days after the last inoculum; Saline/Inoculum (S/I): consisted of three saline inoculums, subcutaneously, at 14-day intervals and a new inoculum performed 14 days after the last inoculum in the sponge implant with 60 μg of Leishmania braziliensis antigen (produced as described by Giunchetti et al. [28]); Vaccine/Saline (V/S): consisted of three inoculums of LBSap vaccine (60 μg of Leishmania braziliensis antigen and 50 μg saponin per dose - produced as described by Giunchetti et al. [28]), subcutaneously, with a 14-day interval; a new inoculum was performed 14 days after the last inoculum in the sponge implant with saline; and an experimental group Vaccine/Inoculum (V/I): consisted of three inoculums of the LBSap vaccine (60 μg of Leishmania braziliensis antigen and 50 μg saponin per dose), subcutaneously, at 14-day interval and a new inoculum performed 14 days after the last inoculum on the sponge implant with 60 μg of Leishmania braziliensis antigen. After 72 hours of the different inoculum in the sponge implants, the animals were euthanized, and the sponges were removed for immunophenotypic analysis and soluble cytokine measurements.

2.4. Flow Cytometry Immunophenotyping

The leukocyte subsets were harvested from sponge implants and analyzed by flow cytometry as previously described Lanna et al.[11]. A panel of fluorescent monoclonal antibodies were used, including anti-CD45 (APC clone 30-F11/E071491630, FITC clone Sa230-F11/E003051630), anti-CD3 (Pe-Cy5 clone 145-2C11/E060661630), anti-CD8 (APC clone 53.6-7/E070561330), anti-CD11c (Pe-Cy5 clone N418/E006121631), F4/80 (FITC clone BM8/E006121631), LY6G (APC clone RB6-8C5/ E001610630), anti-CD197 (PerCPCy5.5 clone 4B12/E0800369258) and anti-CD62L (Pe clone MEL-14/E009159357) from e-Bioscience (San Diego, CA, USA), and anti-CD4 (FITC clone RM4-5/714474A) from Invitrogen (Carlsbad, CA, USA).

The sponges were removed from the implant site and incubated for one hour in a solution containing trypsin, after which the sponge implants were gently squeezed at room temperature in 2mL of RPMI, and the sponge debris was removed by differential centrifugation at 200Xg for 5 minutes at 4ºC. The supernatant was centrifuged at 400xg for 8 minutes at 4ºC to obtain the cell pellet. After resuspension of the cell pellet, the erythrocytes were lysed using 10mL of ammonium chloride buffer. The leukocytes were washed once with 10mL of RPMI at 400xg for 8 minutes at 4ºC. The cell counts were determined with a Neubauer chamber, and the final cell suspension was adjusted to 1x10⁵ cells/mL. Aliquots of 100μL of cell suspension (e.g.,1x10⁴ cells per tube) were incubated in polypropylene tubes containing combinations of 20μL of monoclonal antibody. Following incubation, stained cells were washed once with phosphate-buffered saline (PBS) and resuspended in 250μL of PBS. Nonspecific binding was monitored by using fluorochrome-labeled isotypic matched reagents to provide valid negative controls. Autofluorescence was monitored using a negative control in which the cell suspension was incubated in the absence of fluorochrome-labeled monoclonal antibodies but in the presence of dilution and wash buffers. Flow cytometric measurements were performed on a FACSCanto II^® instrument (Becton Dickinson, Mountain View, CA). A total of 20,000 events were acquired for each sample. The CELLQuestPro software (Franklin Lakes, NJ) was used for data acquisition and storage. FlowJo Software (Flow Cytometry Analysis Software Version 10.1, Tree Star, Inc., Ashland, OR) was used for data analyses.

2.5. Soluble Cytokine Measurements

The sponge implants were homogenized in 1mL of RPMI using a tissue homogenizer (Homo mix). The homogenates were centrifuged at 3,000xg for 10 min at 4⁰C and the supernatants were stored at -80⁰C until processing. Soluble cytokine levels were measured by Cytometric Bead Array (BD Biosciences, San Jose, CA, USA), according to the manufacturer’s recommendations. The mouse inflammation kit was used to measure the levels of soluble IL-6, IL-10, IL-17, IFN-γ, and TNF. FCAP software v.1.0.2 (BD Biosciences) was used for data analysis. The results were presented in median fluorescent intensity (MFI) values.

2.6. Statistical Analysis

Intragroup and intergroup comparative analysis were performed by One-way ANOVA followed by Tukey's multiple comparison test to compare all pairs of data. In all cases, significance was considered at p<0.05. GraphPad Prism (version 5.03, San Diego, California, USA) was used for statistical analysis and graphic arts.

2.7. Biomarker Signature Analysis

The biomarker signature analysis was performed based on the method published by Luiza-Silva et al. which highlights cytokine signatures in innate and adaptive immunity after yellow fever vaccination [36]. This method allows the identification of subtle differences that are not usually detectable by conventional statistical approaches but are relevant for understanding the complex immunological microenvironments that involve multiple events. Biomarker signatures were determined by the frequency of the proportion of implants with biomarker levels above the global median cut-off defined for each biomarker. Thus, to detect the global median cutoff point, the data set was listed in numerical order, from lowest to highest value, after which the median was calculated for each subset of cells (CD45+, Ly+, F4/ 80+, CD11c+, CD3+CD4+, CD3+D8+, CD62L+CCR7+, and CD62L-CCR7-) and each soluble cytokine (IL-6, TNF, IFN-γ, IL-10, and IL-17), using Microsoft Excel software. This approach was performed using all the data for each of the indicated biomarkers, including the data relating to all experimental groups (S/S, S/I, V/S, and V/I) and all three strains of mice (Swiss, BALB/c, and C57BL/6). Based on the global median cutoff, results were categorized as “low” (below the global median) or “high” (above the global median). The categorical data were then used to calculate the proportion (percentage) of implants with biomarker levels above the global median. The curve comprising the ascending frequencies of the biomarkers was created for each experimental group. Biomarkers with frequencies above 75% were considered relevant and highlighted in bold underlined format. Microsoft Excel software was used to assemble radar charts and the final artwork.

3. Results

The data from innate immune response, including the population of total CD45+ leukocytes (LEU) and dendritic cells (CD11c+), macrophages (F4/80+), and neutrophils, (Ly+) are described in Figure 2.

An increase in total CD45+ leukocytes in Swiss mice was observed in the experimental group (V/I) as compared to the other groups (S/S, S/I, and V/S) and BALB/c (S/S and S/I) mice (Figure 2 – upper panel). When the strains were compared, a higher percentage of CD45+ leukocytes were highlighted in Swiss followed by BALB/c and C57BL/6 mice. Regarding the Ly+ neutrophils, an increase was observed in the V/I group of BALB/c mice as compared to the other groups (S/S, S/I, and V/S) (Figure 2 – middle panel). Similarly, the C57BL/6 mice demonstrated higher Ly+ neutrophils in the V/I group as compared to the S/I and V/S groups (Figure 2 – middle panel). Interestingly, Swiss mice had a lower percentage of Ly+ neutrophils in the V/I group as compared to BALB/c mice. F4/80+ macrophages showed a heterogeneous distribution between the experimental groups, but the percentage in all strains was lower in the V/I group as compared to the other groups (Figure 2 – middle panel). When studying CD11c+ dendritic cells in Swiss mice, an increase was reported in the V/S and V/I groups as compared to the other groups (SS/ and S/I) (Figure 2 – bottom panel). In contrast, there were a decrease in the percentage of dendritic cells CD11c+ in the V/I group in BALB/c and C57BL/6 mice in relation to the other groups (S/S, S/I, and V/I).

The adaptive immune response cells were evaluated according to total T-cells (CD3+) and their T-cells subsets (CD3+CD4+ and CD3+CD8+). Also analyzed in those T-cells subsets were the immunological memory biomarkers: CD62L+CCR7+ (central memory) and CD62L-CCR7- (effector memory) (Figure 3). The data described a similar pattern of CD3+CD4+ T-cells in Swiss and C57BL/6 mice with increased counts in the V/I group as compared to the other experimental groups (S/S, S/I, and V/S) (Figure 3 – upper panel). In contrast, the BALB/c mice presented the lowest levels in the CD4+ T-cells in the V/I group as compared to the other two mice strains (Swiss and C57/BL6) (Figure 3). Despite the effector memory (EM) CD4+ T-cells, the Swiss mice presented enhanced levels in the V/S and V/I groups as compared to the S/S group (Figure 3 – middle panel). Similar results were observed in the BALB/c mice, showing higher counts of EM CD4+ T-cells in the V/I group as compared to the S/I group. However, in the C57BL/6, all analyzed groups displayed almost one hundred percent of the CD4+ T-cells EM.

The CD8+ T-cell frequency in Swiss mice showed increased levels in the V/I group as compared to the S/S and S/I groups (Figure 3 – middle panel). The V/I group in BALB/c mice also exhibited an increase as compared to the other three groups (S/S, S/I, and V/S). Although no changes had been observed in the groups of the C57BL/6 mice, the levels of CD3+CD8+ T-cells were the highest in the groups V/S and V/I of Swiss mice as compared to the same groups from BALB/c and C57/BL6. The central memory (CM) CD8+ T-cells in Swiss mice showed lower levels in the V/I group as compared to the other experimental groups (Figure 3 – middle panel). While there was no change in the CM CD8+ T-cells between the groups of C57BL/6 mice, enhanced counts were observed in the V/S group of BALB/c mice as compared to the S/S group. The Swiss mice presented the highest levels of CM CD8+ T-cells in relation to the other mice strains. Concerning effector memory (EM) CD8+ T-cells, the BALB/C mice displayed a decrease in the S/I group as compared to the S/S group, whereas in C57BL/6 mice, the V/I group showed higher levels of this cell population as compared to the S/S group (Figure 3 – bottom panel).

3.2. Cytokine Microenvironment in the Sponge Implants

The cytokine microenvironment in the sponge implants was analyzed to determine the amounts of soluble cytokines (IL-6, TNF, IFN-γ, IL-10, and IL-17). This panel of cytokines was chosen to evaluate the induction of a microenvironment related to an inflammatory or immunomodulatory profile in the microenvironment of the sponge implant. The soluble cytokines in the sponge implant for Swiss, BALB/c, and C57/BL6 mice strains showed higher IL-6 levels in the V/I group as compared to the S/I and V/S groups (Figure 4 – upper panel). There was also an increase in TNF levels in the V/I groups considering all mice strains when compared to the other experimental groups.

Notably, the V/I group in C57BL/6 mice displayed the highest IL-6 levels as compared to Swiss and BALB/c mice strains. Similarly, an increase in IFN-γ levels in all the mice strains was observed for V/I group as compared to the other three experimental groups (S/S, S/I, and V/S) (Figure 4 – middle panel). The IL-10 cytokine analysis revealed increased levels in C57BL/6 mice considering the V/I group as compared to the S/I group (Figure 4 – middle panel). Similar to other inflammatory cytokines, the IL-17 profile demonstrated higher levels in both Swiss and C57BL/6 mice in the V/I group as compared to S/S and S/I groups without changes in the groups of BALB/c mice (Figure 4 – bottom panel).

3.3. Ascendant Biomarker Signature Implants

To characterize the immunophenotypic and functional profile of the immune response in the sponge among the different experimental groups, the ascendant biomarker signatures (from the lowest to the highest frequency) were assembled as shown in Figure 5. Data analysis confirmed most findings detected by conventional statistical methods. The ascendant biomarker signature in sponge implants involves two sets of data referred to as Leukocytes (LEU) Subsets and Cytokine Production.

The biomarker signatures of LEU subsets showed that Swiss mice presented the most prominent immune response to the sponge implant, the vaccine, and the inoculum (Figure 5). The Swiss mice strain displayed higher numbers of cell surface biomarkers with increased levels in all four groups with the recruitment of cytotoxic and central memory immune responses (Figure 5 – upper panel). Moreover, the Swiss mice strain showed an intense inflammatory profile since the highest frequency for TNF, IL-17, and IFN-g was not modulated by IL-10. In contrast, BALB/c mice presented a lower number of cell surface biomarkers with increased levels and a cytokine environment composed of inflammatory cytokines (TNF and IL-6) modulated by IL-10 (Figure 5 – middle panel). Furthermore, the C57BL/6 mice highlighted the T Helper cell surface biomarker with the effector memory component displaying a prominent inflammatory environment with highest frequency of IL-6, TNF, IFN-γ modulated by IL-10 (Figure 5 – bottom panel).

4. Discussion

The sponge model has been widely studied over the past three decades​ [2,5,8,9,12,14,17,18,37,38,39,40,41,42,43,44], including the phenotypic and functional changes that are triggered in distinct mouse lineages ​[11]​. However, the use of this model for trialing antigen candidates for vaccine formulation has not yet been explored as a tool for determining the immunogenicity profile. The present study aimed to evaluate the sponge implant model for improving the understanding of immunogenicity to establish a new model of antigen in vivo testing. The time points for the immune response analysis in the sponge implants were chosen based on the data previously presented for each mouse strain [11]​.

This study described the changes that vaccination and/or antigen inoculation inside the sponge induced in the total leucocytes (CD45+), in the distinct leukocyte subsets harvested from the sponge, in addition to the cytokine environment. The findings showed an increase in the levels of CD45+ leukocytes in the prime-boost protocol (related to group V/I) in two (Swiss and BALB/c) of the mice strains. In Swiss mice, the higher CD45+ leukocyte counts could be explained by the increase in CD11c+ dendritic cells and in T-cells subsets (CD3+CD4+ and CD3+CD8+). Surprisingly, the vaccination in BALB/c and C57BL/6 mice followed by an antigenic boost in the sponge implant (group V/I) showed an increase in the Ly+ neutrophils, while exhibiting a reduction in the levels of CD11+ dendritic cells and F4/80+ macrophages. Furthermore, the increase in Ly+ neutrophils could partially explain the higher percentage of leukocytes in BALB/c. Interestingly, Mendonça et al. observed a reduction in the frequency of neutrophils when analyzing peripheral blood in BALB/c mice 15 days after LBSap vaccination [24]. These results could indicate the migration of neutrophils to the inflammation (vaccine) site triggered in BALB/c mice. Those results highlighted how the genetic background could influence the immune response triggered by prime (vaccine) and boost (antigen inoculation at sponge implant) protocol. The analysis of F4/80+ macrophages demonstrated a similar pattern of cell infiltration since the percentage of these cells in all mice strains was lower as a result of prime-boost protocol (group V/I). In addition, in BALB/c and C57BL/6 mice, the decreased levels of CD11+ dendritic cells after prime-boost protocol (group V/I) could be explained by the migration to lymphoid organs, such as lymph nodes, for antigen presentation​ [45]. It is important to emphasize that in BALB/c mice, an increase in both F4/80+ macrophages and CD11+ dendritic cells were observed in the S/I group. It is possible to hypothesize that the type of inoculum (presence of the antigen), without prior vaccination, could temporally trigger this stimulus since both cell types are specialized in antigen presentation.

An investigation of the adaptive immune response showed that the prime-boost protocol was enough to stimulate the selective migration of CD3+CD4+ T-cells in Swiss and C57BL/6, but not in BALB/c mice. It is important to emphasize that the induction of an increase in the amount of CD3+CD4+ T-cells by anti-visceral leishmaniasis vaccines has been associated with high levels of protection due to the ability of these lymphocytes to produce IFN-γ and promote the activation of macrophages favoring leishmanicidal activity ​[46]​. In contrast, a higher count of CD3+CD8+ T-cells was elicited in the BALB/c mice but at a lower level as compared to Swiss mice (V/I group). The previous vaccination of Swiss mice was effective in increasing the levels of CD3+CD8+ T-cells, while the association with the boost (antigen inoculum in the sponge) was required in BALB/c for the expansion of this T-cell subset. Additionally, it has been reported that the LBSap immunization is able to induce enhanced frequency in the circulating T-cells, including their subsets (CD4+ and CD8+) ​[28]​. Notably, the levels of CD4+ and CD8+ T-cells remained high after L. infantum experimental challenge and it was associated with the protection profile ​[31].

The innate and adaptive immune responses may be related to activation events and maintenance of a protective response profile after vaccination. However, the adaptive response allows the host to trigger an immune memory response, which is of paramount importance in an effective response against pathogens ​[47,48]​. The expansion phase and effector phase of the immune response are followed by an apoptosis phase, during which most antigen-specific T-cells perish. The final phase, or memory phase, is characterized by the maintenance of long-term memory T-cells that retain their antigen specificity and can maintain themselves throughout the life of the host ​[49,50]. Notably, the most important attribute of a memory immune response compared to a primary immune response is its ability to rapidly generate greater numbers of antigen-specific helper T-lymphocytes and cytotoxic agents. Memory T-cells do not prevent reinfection or recurrence of the disease, but they respond quickly and effectively in this scenario, which is one of the bases for the success of several vaccines ​[45,47]​. Memory T-cells can be classified according to their migratory potential, their ability to proliferate, and produce cytokines ​[51,52]​. Briefly, effector memory (EM) T-cells (CD62L-CCR7-) are present in non-lymphoid peripheral tissues and also circulate in the blood. They can migrate through tissues in search of a particular antigen, where they quickly exert effector functions, such as IFN production and cytotoxic activity [50,51]. However, despite existing in large numbers, effector memory T-cells do not have proliferative potential. Thus, a second line of defense is constituted by central memory (CM) cells (CD62L+CCR7+), which reside and circulate among the secondary lymphoid organs. These cells are type 2 interleukin producers and are very sensitive to antigenic stimulation, capable of rapid proliferation ​[45]​.

In summary, EM T-cells provide protection against reinfection or disease reactivation at infection sites, whereas CM T-cells primarily reside in the lymphoid tissue where they rapidly expand and differentiate to replenish the population of effector T-cells. The results of this study demonstrated that Swiss mice are able to trigger an immune response after prime-boost (V/I group) using Leishmania antigens marked by (i) increased CD3+CD4+ T-cells and (ii) CD3+CD8+ T-cells with (iii) effector memory based on CD3+CD4+. In BALB/c mice, this prime-boost antigenic response was based on (i) sustained levels of CD3+CD4+ with (ii) induction in effector memory CD3+CD4+ T-cells and (iii) higher frequency of CD3+CD8+ T-cells. This immune response in C57BL/6 was marked by (i) increased levels in the CD3+CD4+ T-cells, (ii) sustained levels of effector memory CD3+CD4+ T-cells, and (iii) enhanced frequency of effector memory CD3+CD8+ T-cells. In fact, previous data have reported that the LBSap vaccine presented a higher immunogenicity pattern displaying higher levels in the T-cells subsets (CD4+ and CD8+) [28], resulting in improved protection against L. infantum infection [24,31,53,54,55]. Additionally, the sponge implant model was able to further characterize the immune response after prime-boost protocol, providing different mechanisms associated with protection described in the LBSap vaccine in Swiss mice.

Functional analysis of the sponge microenvironment revealed that C57BL/6 mice induced a more prominent response after prime-boost protocol (group V/I) as compared to the other groups, presenting higher levels of cytokines with a mixed activation profile (IL- 6, TNF, IFN-γ, IL-10, and IL-17). In contrast, the cytokine analysis in Swiss mice revealed a prominent inflammatory response mediated mainly by IL-6, TNF, IFN-γ, and IL-17. Additionally, the BALB/c mice showed a similar inflammatory cytokine environment but confined to IL-6, TNF, and IFN-γ. It is important to emphasize that the immune response to an antigen can be determined by the environment in which it is found, being modulated by molecules such as cytokines [56,57]. In fact, the antigen in this microenvironment can trigger a different cytokine production that effectively drives the pattern of the immune response ​[47]​. For example, the production of IFN-γ plays an essential role in inducing antiparasitic responses in macrophages, notably inducing the production of reactive oxygen species (ROS) and nitric oxide synthase (iNOS), essential for killing intracellular pathogens, such as Leishmania ​[58]​. In addition, infection control in visceral leishmaniasis has been related to a Th1-type immune response, in which the pro-inflammatory cytokines IFN-γ /TNF must overcome the effects of the regulatory cytokine (IL-10), while susceptibility is related to a deficient pro-inflammatory response [53,55,59,60]. Some studies also report the importance of the cytokine IL-17 in controlling visceral leishmaniasis and developing vaccines against the disease [61]. According to Pitta et al.​ and Nascimento et al.​, this cytokine plays an important protective role in human visceral leishmaniasis, complementing the protection conferred by inflammatory cytokines in a non-dependent manner or in synergy with IFN-γ, enhancing its action [62,63]. Similar to the data on cellular immune response described in Swiss mice, this strain presented a predominantly pro-inflammatory cytokine profile, reinforcing the applicability of this mice strain for immunogenicity analysis of vaccinal antigens. These data are supported by LBSap studies, demonstrating the presence of a pro-inflammatory cytokine profile (such as IL-6, TNF, IFN-γ, and an increased IFN-γ/IL-10 rate) associated with protection in visceral leishmaniasis [24,53,55,64].

5. Conclusions

The data from this study demonstrated that the implant using a polyester-polyurethane sponge in distinct mice strains provides a reliable in vivo model for immunogenicity studies applied to antigen testing for vaccine candidates. The data described the approach for immunogenicity testing using prime (vaccination) and boost (antigen inoculation at sponge implant), which was able to trigger the innate and adaptive immune responses. The selective stimulation in Ly+ neutrophils and CD11c+ dendritic cells reinforced the ability to assess the innate immune response. Moreover, the adaptive immune response was also induced as demonstrated by the induction in antigen-specific T-cells subsets, corroborating the application of this approach for immunogenicity testing of vaccine (antigens) candidates. In fact, the differential induction on T-cells subsets (CD4+ and CD8+) in the distinct mice strains validated the ability of this model to elicit antigen-specific central and effector memory immune responses. The Swiss mice presented the primary elements for immunogenicity analysis (induction of central memory based on T-cell cytoxicity and an intense inflammatory profile compose by IFN-γ, IL-17 and TNF). Although the BALB/c mice were not marked by a significant influence of adaptive immune response (T-cells memory), the microenvironment elicited in the sponge implant demonstrated a mixed pattern [with inflammatory (TNF, IL-6) and immunomodulatory (IL-10) cytokines]. The C57/BL6 mice showed immune biomarkers related to both Swiss and BALB/c mice with a prominent amount of CD4+ T-cells (including effector memory CD4+ T-cells) and an intense production of inflammatory cytokines (IL-17, IFN-γ, TNF, and IL-6) modulated by IL-10. The results highlighted how genetic background can influence the populations involved in the immune response and indicate that this model could be used to monitor the innate and adaptive immune responses of candidate vaccines. In this sense, these results could guide the choice of the most appropriate experimental model for testing biomolecules, given that the particularities of each mouse strain influenced the dynamics of the innate and adaptive immune responses.